{
    "clinical_study": {
        "@rank": "21774", 
        "arm_group": {
            "arm_group_label": "All subjects", 
            "description": "All subjects"
        }, 
        "brief_summary": {
            "textblock": "A retrospective analysis of historical data looking at hematological remission and survival\n      in adult relapsed / refractory B-precursor acute lymphoblastic leukemia patients."
        }, 
        "brief_title": "Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Acute Lymphoblastic Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Lymphoid", 
                "Precursor Cell Lymphoblastic Leukemia-Lymphoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "A retrospective observational study reviewing historical survival data (hematological\n      remission and survival) for adult patients who have either relapsed or refractory\n      B-precursor acute lymphoblastic leukemia. Data are aggregated across multiple countries and\n      study sites in the EU and US"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult patients with relapsed / refractory B-precursor acute lymphoblastic leukemia\n\n          -  age 15 or older at time of de novo (initial) diagnosis of acute lymphoblastic\n             leukemia\n\n          -  initial diagnosis of acute lymphoblastic leukemia in the year 1990 or later\n\n          -  No CNS involvement at relapse\n\n          -  No isolated extramedullary relapse\n\n          -  Other inclusion criteria may apply"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "15 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adults with relapsed / refractory B-precursor acute lymphoblastic leukemia identified in\n        study group databases from multiple sites in EU and US"
            }
        }, 
        "enrollment": {
            "#text": "2373", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02003612", 
            "org_study_id": "20120310"
        }, 
        "intervention": {
            "arm_group_label": "All subjects", 
            "description": "No intervention exists as this is a retrospective observational study", 
            "intervention_name": "Not applicable - observational study", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 22, 2014", 
        "link": {
            "description": "AmgenTrials clinical trials website", 
            "url": "http://www.amgentrials.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44195"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brno", 
                        "country": "Czech Republic", 
                        "zip": "625 00"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris Cedex 10", 
                        "country": "France", 
                        "zip": "75475"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Frankfurt am Main", 
                        "country": "Germany", 
                        "zip": "60590"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bologna", 
                        "country": "Italy", 
                        "zip": "40138"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Venezia", 
                        "country": "Italy", 
                        "zip": "30174"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gliwice", 
                        "country": "Poland", 
                        "zip": "44-101"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Badalona", 
                        "country": "Spain", 
                        "state": "Catalu\u00f1a", 
                        "zip": "08916"
                    }, 
                    "name": "Research Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "NW3 2PF"
                    }, 
                    "name": "Research Site"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Czech Republic", 
                "France", 
                "Germany", 
                "Italy", 
                "Poland", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "An Analysis of Historical Data on Hematological Remission and Survival Among Adult Patients With Relapsed / Refractory B-Precursor Acute Lymphoblastic Leukemia", 
        "overall_official": {
            "affiliation": "Amgen", 
            "last_name": "MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Germany: Ethic commission of the faculty of medicine, University of Frankfurt", 
                "France: CCTIRS (comit\u00e9 consultative sur le traitement de l'information en mati\u00e8re de recherche dans le domaine de la sant\u00e9)", 
                "France: CNIL (Commission Nationale de L'informatique et Libert\u00e9)", 
                "France: CNOM (Conseil National de L'ordre des m\u00e9decins)", 
                "Spain: Ethics Committee: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica del Hospital Universitario Germans Tr\u00edas i Pujol", 
                "Czech Republic: Ethics Committee", 
                "Poland: Ethics Committee", 
                "United Kingdom: Research Ethics Committee", 
                "United States: Institutional Review Board", 
                "Italy: Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "To estimate the proportion of patients in hematological complete remission (CR) for R/R Philadelphia chromosome negative (Ph-) B-precursor ALL patients following relapse or salvage treatment, excluding patients with a first remission duration of >12 months in first salvage (ie, patients with late relapse in first salvage)", 
            "measure": "hematological complete remission", 
            "safety_issue": "No", 
            "time_frame": "Approx 1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02003612"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "to estimate overall survival for relapsed / refractory philadelphia negative B-precursor acute lymphoblastic leukemia patients following salvage treatment, excluding patients with late relapse in first salvage", 
                "measure": "overall survival", 
                "safety_issue": "No", 
                "time_frame": "Approx 1 year"
            }, 
            {
                "description": "to estimate the duration of complete remission for philadelphia negative patients following treatment for relapsed / refractory B-precursor acute lymphoblastic leukemia, excluding patients with late relapse in first salvage", 
                "measure": "duration of complete remission", 
                "safety_issue": "No", 
                "time_frame": "Approx 1 year"
            }, 
            {
                "description": "estimate the proportion of patients receiving allogeneic hematological stem cell transplantation for philadelphia negative patients following treatment for relapsed / refractory B-precursor acute lymphoblastic leukemia excluding those with late relapse in first salvage", 
                "measure": "proportion of patients receiving allogeneic hematological stem cell transplantation", 
                "safety_issue": "No", 
                "time_frame": "Approx 1 year"
            }
        ], 
        "source": "Amgen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Amgen", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}